ArticleJournal of clinical medicine2025

BRCA1 and 2 Mutations and Efficacy of Pembrolizumab-Based Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer: A Real-World Multicenter Analysis.

Palma Fedele et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.